Core Viewpoint - The A-share market is experiencing a downward trend, with the Shanghai Composite Index down by 1.03% and a total trading volume of 845.1 billion yuan as of 10:31 AM [1] Group 1: Market Performance - The Shanghai Composite Index is at 3828.24 points, reflecting a decrease of 1.03% [1] - A total of 136 A-shares have seen their 5-day moving averages cross below their 10-day moving averages, indicating potential bearish trends [1] Group 2: Individual Stock Analysis - The stocks with the largest negative distance between their 5-day and 10-day moving averages include: - Pinming Technology (688109) with a 5-day moving average of 150.91 yuan, down 4.02% from the 10-day moving average [1] - Guomai Technology (002093) with a 5-day moving average of 12.42 yuan, down 1.79% from the 10-day moving average [1] - Anbang Security (603373) with a 5-day moving average of 39.65 yuan, down 1.75% from the 10-day moving average [1] Group 3: Additional Stock Movements - Other notable stocks with negative movements include: - Yatai Pharmaceutical (002370) down 1.82% with a 5-day moving average of 7.28 yuan [1] - Kaisa Culture (002425) down 3.93% with a 5-day moving average of 3.93 yuan [1] - ST Saiwei (300044) down 0.97% with a 5-day moving average of 4.25 yuan [2]

每日经济新闻 每经AI快讯，12月10日，医药商业板块短线走低，瑞康医药跌超7%，润达医疗、人民同泰、塞力医 疗、鹭燕医药等跟跌。 ...

证券日报网讯 12月5日，润达医疗在互动平台回答投资者提问时表示，目前公司的AI智能体产品还在与 鸿蒙系统适配中，公司AI业务的落地动态会通过公司微信公众号发布。 （文章来源：证券日报） ...

证券日报网讯 12月5日，润达医疗（603108）在互动平台回答投资者提问时表示，公司始终坚持以AI创 新赋能医疗场景，依托自身积累的AI技术优势及国资控股的平台资源优势，积极参与了杭州国家人工 智能医疗应用中试基地建设，发布会新闻中提及的杭州市"家医有约"综合服务平台，以及以杭州市第一 人民医院为试点在市级医疗机构全面开展预问诊、医疗文书辅助生成和病历质控等AI应用的病历辅助 生成方面，公司均深度参与了其中的建设工作。未来，公司还将继续依托在AI领域深厚的技术积累和 产品优势，为杭州国家人工智能医疗应用中试基地建设贡献更多的力量。 ...

Core Viewpoint - The company has launched a new AI integrated solution for smart hospitals in collaboration with Huawei and Huakun, which has received positive feedback from the market and shows promising commercial prospects [2]. Group 1: Product Launch and Features - The company, in partnership with Huawei and Huakun, introduced the latest smart hospital AI integrated machine solution, emphasizing "full scene coverage, hardware-software integration, and plug-and-play" advantages [2]. - The solution features three breakthroughs: customized development through scene feedback, an end-to-end hardware-software collaborative system, and exceptional cost-performance ratio, significantly reducing deployment costs [2]. Group 2: Market Response and Commercial Progress - Hospital clients have shown strong reactions to the newly launched lightweight integrated machine product solutions [2]. - As of now, the company has signed contracts for over 90 integrated machines and has more than 200 potential clients, indicating robust market interest [2]. - The company and its partners are accelerating the development of the integrated machine filling system to meet customer delivery demands [2].

Core Viewpoint - The company, RunDa Medical, has launched a new AI integrated solution for smart hospitals in collaboration with Huawei and Huakun Zhenyu, emphasizing cost reduction and ease of deployment [1] Group 1: Product Launch - The new AI integrated machine solution features "full scene coverage, hardware-software integration, and out-of-the-box usability" as its core advantages [1] - The solution includes three major breakthroughs: custom development through scenario feedback, an end-to-end hardware-software collaborative system, and exceptional cost-performance ratio [1] Group 2: Market Response - Hospital clients have shown strong positive feedback towards the newly launched lightweight integrated machine product solution [1] - As of now, the company has signed contracts for over 90 units of the integrated machine, with more than 200 potential clients expressing interest [1] Group 3: Operational Focus - The company and its partners are accelerating the development of the integrated machine filling system to meet customer delivery demands [1]

格隆汇12月5日丨润达医疗(603108.SH)在互动平台表示，目前公司的AI智能体产品还在与鸿蒙系统适配 中，公司AI业务的落地动态会通过公司微信公众号发布。 （原标题：润达医疗(603108.SH)：AI智能体产品还在与鸿蒙系统适配中） ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | 资产负债率为 | 70%以上的全资及控股子公司 | | | | | --- | --- | --- | --- | --- | | 担保对 | 被担保人名称 | | 杭州润达医疗管理有限公司 | | | | 本次担保金额 | 23,360 | 万元 | | | 象一 | 实际为其提供的担保余额 | 156,617.39 | 万元 | | | | 是否在前期预计额度内 是 | | □否 | □不适用：_________ | | | 本次担保是否有反担保 □是 | | 否 | □不适用：_________ | | 担保对 | 被担保人名称 | | | 安徽泽芬生物科技有限公司 | | | 本次担保金额 2,000 | | 万元 | | | 象二 | 实际为其提供的担保余额 7,500 | | 万元 | | | | 是否在前期预计额度内 是 | | □否 | □不适用：_________ | | | 本次担保是否有反担保 是 | | □否 ...

Core Viewpoint - The announcement details the release of shareholdings from freezing for shareholders Liu Hui and Zhu Wenyi, which may have implications for the company's stock liquidity and shareholder dynamics [2][4]. Shareholder Information - Liu Hui holds 31,528,771 shares, representing 5.22% of the total share capital. The number of shares released from freezing is 18,994,771, leaving 2,904,000 shares frozen, which is 9.21% of his holdings and 0.48% of the total share capital [2]. - Zhu Wenyi holds 31,518,408 shares, also 5.22% of the total share capital. The released shares amount to 1,189,056, with no remaining frozen shares [2]. - Liu Hui and Zhu Wenyi are acting in concert, collectively holding 63,047,179 shares, or 10.44% of the total share capital, with a total of 2,904,000 shares frozen, which is 4.61% of their holdings and 0.48% of the total share capital [2]. Frozen Shares Background - The shares of Liu Hui and Zhu Wenyi were frozen on October 20, 2025, as detailed in a previous announcement [2][3]. Impact on the Company - The release of shares from freezing is not expected to significantly impact the company's operations, as Liu Hui and Zhu Wenyi are not the controlling shareholders or actual controllers of the company [4].

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 上海润达医疗科技股份有限公司（以下简称"公司"）于今日获悉公司股东刘 辉先生和朱文怡女士的部分股份已解除冻结，具体情况如下： 一、本次解除冻结股份的原冻结情况 公司股东刘辉先生及朱文怡女士的部分股份于 2025 年 10 月 20 日被冻结， 具体内容详见公司于 2025 年 10 月 23 日披露的《股东股份冻结的公告》（编号： 临 2025-055）。 | 证券代码：603108 | 证券简称：润达医疗 | 公告编号：临 2025-058 | | --- | --- | --- | | 转债代码：113588 | 转债简称：润达转债 | | 上海润达医疗科技股份有限公司 股东股份解除冻结的公告 | 占其所持股份比例 | 60.25% | | | 3.77% | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 占公司总股本比例 | 3.15% | | | 0.20% | | | | | 解除冻结 ...